A Parkinson's disease project from the lab of chemist Matthew D. Disney, Ph.D., has received a boost from a nonprofit focused on helping scientists translate their discoveries into treatments.
Molecular biologist Ezgi Hacisuleyman, Ph.D., investigates how neurons respond to signals, changing in milliseconds. She recently joined the institute from The Rockefeller University.
A new discovery from the lab of chemist Matthew Disney, Ph.D., takes its inspiration from Greek mythology. The compound is a chimera, and it battles a toxic cause of Parkinson's in two ways.
The scientists’ approach directs cells’ recycling enzymes to cancer genes’ RNA and cuts up key segments to prevent them from doing harm. The tactic worked against the MYC cancer gene, and also two other challenging cancer genes.
Matthew Disney, Ph.D. has been named the first Institute Professor of The Wertheim UF Scripps Institute. Disney invented a search-and-destroy system for incurable diseases that targets RNA.
It was the first major scientific conference at the institute since the pandemic began, and so researchers relished the opportunity to share recent work and reconnect.
January 17-18, 2023 The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology Rodney B. Fink Auditorium 120 Scripps Way, Jupiter, Florida 33458 RNA: From Biology to Drug Discovery See RNA Symposium Highlights and Photos…
The findings show it is possible to substantially accelerate the drug discovery process. The technique opens new doors to treating diseases by targeting their RNA processes, said Disney.
As cells are building proteins, the process is occasionally halted in error prior to completion. How cells sense these glitches is clearer thanks to Joazeiro lab.
The Karbstein lab has discovered how ribosomes are remodeled in response to stress, altering their protein output.
